Pactiv Evergreen Inc. Common stock

PTVE

Market cap $3.27B

LAKE FOREST, Ill., March 28, 2025 (GLOBE NEWSWIRE) --  Pactiv Evergreen Inc. (“Pactiv Evergreen” or the “Company”) (NASDAQ: PTVE) today announced that all required regulatory approvals have been received in connection with the Company's previously announced definitive agreement to be acquired by Novolex® for $18.00 per share in cash.

As of Feb. 25, 2025, three stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Pactiv Evergreen Inc. ("Pactiv Evergreen" or "the Company") (NASDAQ:PTVE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Pactiv Evergreen board breached its fiduciary duties to shareholders.

LOS ANGELES, CA / ACCESS Newswire / February 12, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Pactiv Evergreen Inc. ("Pactiv Evergreen" or "the Company") (NASDAQ:PTVE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Pactiv Evergreen board breached its fiduciary duties to shareholders.

LOS ANGELES, CA / ACCESS Newswire / February 11, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Pactiv Evergreen Inc. ("Pactiv Evergreen" or "the Company") (NASDAQ:PTVE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Pactiv Evergreen board breached its fiduciary duties to shareholders.

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Pactiv Evergreen Inc. ("Pactiv Evergreen" or "the Company") (NASDAQ:PTVE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Pactiv Evergreen board breached its fiduciary duties to shareholders.

LOS ANGELES, CA / ACCESS Newswire / February 9, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Pactiv Evergreen Inc. ("Pactiv Evergreen" or "the Company") (NASDAQ:PTVE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Pactiv Evergreen board breached its fiduciary duties to shareholders.

LOS ANGELES, CA / ACCESS Newswire / February 8, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Pactiv Evergreen Inc. ("Pactiv Evergreen" or "the Company") (NASDAQ:PTVE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Pactiv Evergreen board breached its fiduciary duties to shareholders.

LOS ANGELES, CA / ACCESS Newswire / February 7, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Pactiv Evergreen Inc. ("Pactiv Evergreen" or "the Company") (NASDAQ:PTVE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Pactiv Evergreen board breached its fiduciary duties to shareholders.

LOS ANGELES, CA / ACCESS Newswire / February 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Pactiv Evergreen Inc. ("Pactiv Evergreen" or "the Company") (NASDAQ:PTVE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Pactiv Evergreen board breached its fiduciary duties to shareholders.